[1]
“Berotralstat: A data review of a novel oral medication for the treatment of hereditary angioedema”, Can Allergy Immunol Today, vol. 4, no. 01-2, pp. 2–8, Jan. 2024, doi: 10.58931/cait.2024.4s0161.